Brentuximab, CAS [[2088770-90-3]]

Produktübersicht

• Artikelname: Brentuximab, CAS [[2088770-90-3]]
• Artikelnummer: MCE-HY-P99151
• Hersteller Artikelnummer: HY-P99151
• Alternativnummer: MCE-HY-P99151-10MG,MCE-HY-P99151-50MG,MCE-HY-P99151-100MG,MCE-HY-P99151-5MG,MCE-HY-P99151-1MG,MCE-HY-P99151-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: CAC-10

Produktbeschreibung

Brentuximab is a monoclonal antibody targeting CD30. Brentuximab is conjugated with monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107), which can induce apoptosis in primary effusion lymphoma cells. Brentuximab vedotin exhibits antitumor activity with an IC50 of 10 nM against human CD30+ cancer cells[1][2][3].

Produkteigenschaften

• Molekulargewicht: (145.48 kDa)
• Reinheit: 99.64
• CAS Nummer: [2088770-90-3]
• Target-Kategorie: ADC Antibody,TNF Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies